Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Rat Rotator Cuff Lipidomics (Study ST000666)

C18 NEGATIVE ION MODE (Analysis AN001018)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8
CL 84:15; [M-2H](2-)@5.56	ME180989	2.56	0.32	0.41	0.74	3.03	0.24	0.34	0.35
PE 38:7; [M-H]-@4.44	ME181104	2.20	0.35	0.39	0.23	4.11	0.22	0.30	0.19
PS 22:0; [M-H]-@1.75	ME181188	2.05	0.09	0.31	0.36	4.49	0.17	0.29	0.25
CL 72:7; [M-2H](2-)@4.51	ME180929	1.49	0.25	0.47	0.72	3.84	0.22	0.69	0.32
lysoPE 22:5; [M-H]-@1.44	ME181215	1.81	0.26	0.40	0.44	4.09	0.29	0.34	0.36
lysoPE 22:6; [M-H]-@1.24	ME181216	1.75	0.40	0.44	0.53	3.71	0.41	0.34	0.42
CL 70:2; [M-2H](2-)@8.49	ME180917	1.41	0.21	0.30	3.96	0.92	0.33	0.52	0.35
PC 36:6; [M-Ac-H]-@5.34	ME181036	1.23	3.01	0.73	0.34	0.60	0.74	0.96	0.40
CL 82:9; [M-2H](2-)@6.35	ME180986	0.68	0.97	0.45	1.44	0.54	2.65	0.37	0.90
PE 43:6; [M-H]-@5.97	ME181134	0.31	1.18	0.42	1.61	1.85	1.23	0.71	0.68
MGDG 40:6; [M-H]-@6.13	ME180994	0.68	1.19	0.65	1.92	1.29	0.83	0.73	0.72
PC 35:0; [M-Ac-H]-@7.72	ME181023	1.07	1.07	0.61	1.73	1.25	0.93	0.51	0.83
CL 72:7; [M-2H](2-)@9.08	ME180928	1.12	0.87	0.60	1.87	1.17	0.85	0.22	1.30
CL 76:11; [M-2H](2-)@8.89	ME180941	1.43	0.69	0.59	1.87	1.29	0.54	0.41	1.18
CL 72:6; [M-2H](2-)@9.25	ME180927	0.91	0.65	0.64	2.93	0.89	0.62	0.64	0.72
PS 42:6; [M-H]-@6.40	ME181206	1.21	0.80	1.06	2.15	0.66	0.73	0.60	0.80
CL 78:9; [M-2H](2-)@5.77	ME180966	0.36	0.90	1.19	0.98	0.56	0.92	1.04	2.05
PI 40:3; [M-H]-@5.24	ME181183	0.60	0.65	0.87	0.89	1.07	1.14	0.60	2.18
PE 32:1; [M-H]-@6.21	ME181059	0.39	0.77	1.57	0.83	0.46	0.81	2.38	0.79
CL 66:3; [M-2H](2-)@5.74	ME180912	0.53	0.60	1.31	0.51	0.75	0.59	3.08	0.63
CL 66:1; [M-2H](2-)@6.21	ME180910	0.57	0.67	1.55	0.58	0.54	0.62	2.70	0.76
PE 32:2; [M-H]-@5.68	ME181060	0.45	0.77	1.16	0.63	0.62	0.81	2.80	0.76
PE 36:0; [M-H]-@7.85	ME181076	0.54	1.61	0.96	0.99	0.45	0.70	1.45	1.29
PC 34:4; [M-Ac-H]-@5.54	ME181021	0.26	1.06	1.55	1.00	0.35	1.13	1.36	1.29
PS 38:3; [M-H]-@6.18	ME181195	0.28	0.95	1.42	1.32	0.37	1.02	1.23	1.41
PG 32:1; [M-H]-@5.22	ME181137	0.73	0.54	1.62	1.35	0.63	0.46	1.62	1.06
PS 34:2; [M-H]-@5.28	ME181190	0.73	0.86	1.77	1.07	0.68	0.61	1.49	0.78
PE 35:4; [M-H]-@6.03	ME181075	0.92	1.22	1.24	0.57	0.61	1.27	1.43	0.76
PG 36:4; [M-H]-@4.86	ME181152	0.38	1.23	1.37	0.54	0.41	1.70	1.86	0.52
PG 36:3; [M-H]-@5.34	ME181151	0.56	1.06	1.37	0.67	0.48	1.30	1.91	0.64
PG 38:6; [M-H]-@4.73	ME181159	0.64	0.96	1.22	0.76	0.60	1.55	1.65	0.62
plasmenyl-PE 34:3; [M-H]-@6.31	ME181224	0.65	1.21	1.33	0.62	0.71	1.33	1.63	0.51
PI 36:1; [M-H]-@6.27	ME181174	0.42	0.98	1.41	1.31	0.59	1.00	1.42	0.88
PI 38:5; [M-H]-@5.34	ME181181	0.54	1.02	1.51	0.91	0.64	0.93	1.51	0.95
PS 34:1; [M-H]-@5.77	ME181189	0.49	1.03	1.57	0.69	0.58	1.01	1.66	0.98
PS 38:4; [M-H]-@5.94	ME181196	0.48	0.97	1.48	0.85	0.42	1.04	1.68	1.09
PC 32:1; [M-Ac-H]-@6.12	ME181010	0.64	1.12	1.23	0.96	0.57	1.17	1.49	0.81
PE 34:2; [M-H]-@5.64	ME181067	0.66	1.16	1.15	0.88	0.69	0.86	1.62	0.99
PI 34:2; [M-H]-@5.21	ME181173	0.68	1.01	1.30	0.84	0.80	1.02	1.44	0.91
plasmenyl-PE 32:1; [M-H]-@6.57	ME181218	0.72	0.87	1.28	0.84	0.66	1.01	1.64	0.98
PE 35:3; [M-H]-@6.19	ME181074	0.74	0.70	1.50	0.95	0.58	0.63	1.68	1.23
PE 34:1; [M-H]-@6.84	ME181065	0.67	0.71	1.44	0.91	0.70	0.83	1.88	0.87
CL 72:5; [M-2H](2-)@5.70	ME180925	0.85	0.64	1.39	0.75	0.84	0.63	1.89	1.02
CL 72:5; [M-2H](2-)@6.21	ME180926	0.87	0.70	1.42	0.76	0.62	0.64	1.93	1.04
CL 68:3; [M-2H](2-)@6.08	ME180914	0.99	1.09	1.11	0.79	0.78	0.84	1.67	0.72
CL 72:7; [M-2H](2-)@6.04	ME180930	0.91	0.94	1.48	0.52	0.64	0.85	1.88	0.80
CL 78:13; [M-2H](2-)@5.38	ME180957	0.89	0.81	1.24	0.63	0.77	0.92	1.93	0.80
CL 78:13; [M-2H](2-)@5.84	ME180956	0.89	0.81	1.24	0.63	0.77	0.92	1.93	0.80
CL 66:2; [M-2H](2-)@5.73	ME180911	0.73	0.91	1.12	0.60	0.76	1.00	2.25	0.64
PG 34:3; [M-H]-@4.72	ME181143	0.68	0.83	1.05	0.70	0.75	1.15	2.20	0.62
PE 36:5; [M-H]-@5.85	ME181084	0.43	1.02	1.07	0.84	0.45	1.03	2.19	0.97
PE 34:3; [M-H]-@5.90	ME181069	0.50	0.94	1.27	0.73	0.55	0.97	2.07	0.97
PE 38:7; [M-H]-@5.50	ME181105	0.63	0.93	1.33	0.65	0.66	1.00	1.90	0.90
PE 38:7; [M-H]-@5.66	ME181106	0.63	0.93	1.33	0.65	0.66	1.00	1.90	0.90
CL 70:5; [M-2H](2-)@5.97	ME180918	0.60	0.83	1.30	0.61	0.67	0.83	2.33	0.82
CL 74:9; [M-2H](2-)@5.74	ME180938	0.67	0.90	1.14	0.75	0.55	0.89	2.21	0.89
lysoPE 18:1; [M-H]-@1.81	ME181211	0.80	0.93	1.23	0.70	1.42	0.87	1.48	0.57
PE 33:1; [M-H]-@6.57	ME181061	0.80	0.89	1.20	0.80	1.06	1.02	1.36	0.86
PE 33:2; [M-H]-@6.04	ME181062	0.62	1.01	1.21	0.86	0.99	1.03	1.55	0.73
CL 78:3; [M-2H](2-)@7.51	ME180960	0.86	0.62	1.23	0.85	0.97	0.66	1.46	1.34
PG 34:1; [M-H]-@5.77	ME181141	1.07	0.53	1.27	0.93	1.03	0.59	1.51	1.07
PE 42:10; [M-H]-@5.80	ME181128	1.33	0.70	1.34	0.57	1.02	0.75	1.47	0.82
CL 70:1; [M-2H](2-)@6.84	ME180915	0.98	0.64	1.35	0.83	0.93	0.69	1.79	0.79
CL 76:9; [M-2H](2-)@5.80	ME180950	1.02	0.69	1.35	0.79	0.92	0.86	1.55	0.83
CL 78:10; [M-2H](2-)@6.12	ME180953	1.18	0.83	1.22	0.89	0.96	0.72	1.42	0.79
CL 78:1; [M-2H](2-)@7.93	ME180951	1.13	0.60	1.26	1.07	0.95	0.67	1.57	0.76
PG 40:6; [M-H]-@5.32	ME181161	0.52	0.96	1.18	0.97	0.98	0.88	1.10	1.41
PE 44:4; [M-H]-@8.56	ME181135	1.00	0.98	0.92	1.18	0.49	0.94	1.45	1.05
PG 38:5; [M-H]-@5.12	ME181157	1.06	0.81	1.01	1.00	0.65	1.17	1.45	0.85
PG 35:2; [M-H]-@5.68	ME181146	1.19	0.66	1.14	1.30	0.84	0.71	1.32	0.83
PC 38:2; [M-Ac-H]-@7.49	ME181043	0.89	0.79	0.91	1.21	0.84	0.94	1.19	1.23
plasmenyl-PE 38:2; [M-H]-@7.79	ME181233	0.72	0.95	1.02	1.16	0.84	0.80	1.31	1.20
CL 74:1; [M-2H](2-)@7.43	ME180932	0.87	0.87	1.16	1.13	0.95	0.81	1.16	1.06
PE 36:4; [M-H]-@6.19	ME181083	0.76	0.98	1.13	1.03	0.94	0.87	1.24	1.04
PG 33:1; [M-H]-@5.51	ME181139	1.09	0.74	1.17	1.16	0.88	0.68	1.18	1.09
PE 37:2; [M-H]-@7.21	ME181087	1.09	0.75	1.03	1.16	0.99	0.72	0.99	1.28
PE 35:2; [M-H]-@6.35	ME181072	0.96	0.75	1.10	1.04	1.05	0.84	1.11	1.16
PE 35:2; [M-H]-@6.71	ME181073	0.96	0.75	1.10	1.04	1.05	0.84	1.11	1.16
PI 40:7; [M-H]-@5.24	ME181187	0.98	0.80	1.07	1.19	0.91	0.89	1.06	1.10
PE 36:2; [M-H]-@6.99	ME181080	0.96	0.84	1.04	1.15	1.07	0.78	0.96	1.21
PE 38:6; [M-H]-@6.13	ME181103	0.91	0.89	1.11	1.20	0.98	0.76	1.02	1.14
PG 32:0; [M-H]-@5.71	ME181136	0.89	0.83	1.34	1.00	0.78	0.76	1.06	1.34
CL 78:4; [M-2H](2-)@7.01	ME180961	0.85	1.04	1.06	0.96	0.88	0.95	0.97	1.28
PG 34:0; [M-H]-@6.30	ME181140	0.92	0.88	1.11	0.96	0.85	0.88	1.17	1.23
PG 35:1; [M-H]-@6.09	ME181145	0.92	0.82	1.12	1.03	0.88	0.93	1.07	1.23
plasmenyl-PE 40:4; [M-H]-@7.69	ME181238	0.87	0.88	1.04	1.07	0.92	0.85	1.50	0.87
CL 72:1; [M-2H](2-)@7.13	ME180920	0.81	0.79	1.27	1.08	1.07	0.76	1.33	0.88
PE 34:2; [M-H]-@6.39	ME181068	1.02	0.84	1.06	1.01	1.10	0.78	1.26	0.93
plasmenyl-PE 34:1; [M-H]-@7.11	ME181222	1.00	0.78	1.08	1.08	0.99	0.76	1.33	0.98
CL 78:8; [M-2H](2-)@6.24	ME180965	0.82	0.75	1.16	1.06	0.77	0.81	1.64	0.98
CL 74:4; [M-2H](2-)@6.04	ME180936	0.90	0.76	1.31	0.93	0.85	0.71	1.48	1.07
PE 36:3; [M-H]-@6.51	ME181082	0.76	0.77	1.35	0.94	0.79	0.77	1.61	1.01
PE 38:1; [M-H]-@7.90	ME181093	0.90	0.74	1.29	1.28	0.78	0.68	1.35	0.99
PG 38:4; [M-H]-@6.04	ME181155	0.84	0.65	1.23	1.14	0.86	0.81	1.23	1.24
PE 36:1; [M-H]-@7.43	ME181078	0.70	0.79	1.21	1.28	0.81	0.81	1.30	1.09
PE 38:2; [M-H]-@7.51	ME181094	0.71	0.76	1.16	1.17	0.74	0.81	1.47	1.17
PE 35:1; [M-H]-@7.11	ME181071	0.76	1.02	1.29	1.20	0.67	0.75	1.20	1.12
PE 42:4; [M-H]-@7.85	ME181129	0.80	0.95	1.50	1.07	0.78	0.77	1.25	0.89
PI 36:3; [M-H]-@5.35	ME181176	0.83	0.97	1.20	1.06	0.70	0.95	1.36	0.94
PI 36:4; [M-H]-@5.22	ME181177	0.78	0.92	1.22	0.96	0.68	1.09	1.22	1.13
plasmenyl-PE 33:1; [M-H]-@6.87	ME181220	0.80	0.76	1.47	0.93	0.63	1.08	1.33	1.00
PE 38:5; [M-H]-@6.47	ME181101	0.71	0.85	1.33	0.94	0.77	0.96	1.37	1.08
PS 38:5; [M-H]-@5.40	ME181197	0.73	0.89	1.38	0.91	0.67	1.02	1.37	1.04
PE 37:5; [M-H]-@5.94	ME181090	0.94	0.84	1.23	0.82	0.85	0.95	1.40	0.98
PE 37:5; [M-H]-@6.19	ME181089	0.96	0.86	1.26	0.75	0.77	0.97	1.44	1.00
PG 38:3; [M-H]-@5.96	ME181154	1.11	0.79	1.29	0.79	0.84	1.09	1.06	1.02
PE 32:0; [M-H]-@6.72	ME181058	0.94	0.86	1.31	0.87	0.86	1.04	1.19	0.92
PE 42:9; [M-H]-@6.13	ME181133	1.03	0.89	1.21	0.94	0.85	0.91	1.17	1.00
PE 40:2; [M-H]-@7.98	ME181112	0.69	0.74	1.16	1.70	0.70	0.74	1.15	1.12
CL 82:5; [M-2H](2-)@7.09	ME180981	0.74	0.72	1.08	1.33	0.82	0.94	0.92	1.44
CL 70:7; [M-2H](2-)@8.81	ME180919	0.84	0.99	0.89	1.55	0.69	0.65	0.98	1.41
PE 40:3; [M-H]-@7.76	ME181113	0.75	1.09	0.99	1.33	0.77	0.75	1.04	1.28
PE 34:0; [M-H]-@6.61	ME181063	0.55	0.90	0.95	1.15	0.68	1.08	1.44	1.24
plasmenyl-PE 36:4; [M-H]-@6.64	ME181230	0.56	1.09	1.20	1.21	0.57	1.17	1.08	1.11
plasmenyl-PE 38:4; [M-H]-@7.22	ME181235	0.52	1.17	1.14	1.10	0.51	1.19	1.21	1.15
PS 36:2; [M-H]-@5.80	ME181192	0.52	1.18	1.20	1.12	0.57	1.03	1.21	1.16
PS 40:5; [M-H]-@6.03	ME181200	0.62	0.94	1.21	1.23	0.58	1.05	1.06	1.32
PG 38:4; [M-H]-@5.46	ME181156	0.60	0.98	1.37	1.15	0.64	1.10	0.99	1.18
PS 36:1; [M-H]-@5.87	ME181191	0.57	1.02	1.28	1.32	0.68	0.96	1.01	1.17
PG 40:7; [M-H]-@5.00	ME181162	0.45	1.17	0.98	1.13	0.55	1.35	1.09	1.29
plasmenyl-PE 36:5; [M-H]-@6.28	ME181231	0.44	1.24	1.09	1.17	0.50	1.32	0.96	1.29
PG 40:9; [M-H]-@4.17	ME181164	0.65	1.41	0.78	1.12	0.62	1.09	1.16	1.18
CerP 34:1; [M-H]-@5.86	ME180992	0.66	1.26	0.93	1.16	0.71	1.07	1.00	1.22
plasmenyl-PE 42:4; [M-H]-@8.07	ME181241	0.70	1.14	0.97	1.22	0.58	1.11	1.03	1.25
plasmenyl-PE 42:6; [M-H]-@7.75	ME181242	0.73	1.04	0.91	1.21	0.68	1.11	1.08	1.22
PE 36:0; [M-H]-@7.26	ME181077	0.58	1.14	0.95	1.39	0.66	1.23	0.91	1.13
plasmenyl-PE 38:3; [M-H]-@7.53	ME181234	0.51	1.37	0.94	1.35	0.53	1.17	0.95	1.18
PE 38:1; [M-H]-@7.36	ME181092	0.88	0.94	0.72	1.30	0.72	1.34	1.02	1.08
PG 33:0; [M-H]-@6.02	ME181138	0.68	0.98	0.88	1.15	0.90	1.44	0.97	1.01
PE 37:1; [M-H]-@7.62	ME181086	0.76	1.11	0.84	1.41	0.89	1.10	0.99	0.89
plasmenyl-PE 38:1; [M-H]-@8.19	ME181232	0.77	1.08	1.03	1.25	0.98	0.99	1.07	0.83
plasmenyl-PE 38:5; [M-H]-@6.76	ME181236	0.74	0.98	1.10	1.12	0.82	1.10	1.17	0.97
PE 38:4; [M-H]-@6.99	ME181098	0.80	1.09	1.04	0.92	0.83	1.03	1.20	1.10
plasmenyl-PE 36:3; [M-H]-@6.91	ME181229	0.78	1.12	1.16	0.96	0.78	1.13	1.08	1.00
PC 34:3; [M-Ac-H]-@5.80	ME181020	0.77	1.12	0.93	1.03	0.74	1.16	1.32	0.94
PS 38:2; [M-H]-@5.90	ME181194	0.77	1.12	0.93	1.03	0.74	1.16	1.32	0.94
PG 36:1; [M-H]-@6.43	ME181148	0.90	1.02	1.03	0.93	0.83	1.28	1.15	0.85
PC 32:0; [M-Ac-H]-@6.62	ME181009	0.89	0.99	0.94	1.13	0.80	1.26	1.12	0.88
PC 33:1; [M-Ac-H]-@6.45	ME181013	0.90	1.05	0.88	1.05	0.90	1.12	1.20	0.89
PG 44:10; [M-H]-@5.06	ME181169	0.84	0.91	0.95	1.03	0.85	1.23	0.91	1.29
PG 42:9; [M-H]-@4.81	ME181168	0.77	1.03	1.01	1.20	0.75	1.09	0.90	1.25
PI 37:4; [M-H]-@5.53	ME181178	0.78	1.11	1.12	1.04	0.84	1.13	0.91	1.07
PI 38:4; [M-H]-@5.82	ME181180	0.84	1.02	1.15	1.09	0.79	1.09	0.85	1.17
PE 38:2; [M-H]-@6.87	ME181095	0.79	1.17	0.92	1.12	1.01	0.98	0.82	1.18
PE 34:1; [M-H]-@6.12	ME181066	0.67	1.13	1.03	1.22	0.92	0.95	0.85	1.23
PE 36:1; [M-H]-@6.74	ME181079	0.73	1.10	0.99	1.34	0.92	0.94	0.76	1.22
PC 37:2; [M-Ac-H]-@7.21	ME181038	0.90	1.25	0.87	1.17	0.80	0.89	0.93	1.19
PE 38:3; [M-H]-@7.22	ME181096	0.74	1.32	0.98	1.07	0.82	1.01	1.01	1.05
PG 35:0; [M-H]-@6.29	ME181144	0.66	1.17	1.00	1.54	0.72	1.04	0.75	1.12
PS 40:4; [M-H]-@6.37	ME181199	0.61	1.17	1.05	1.45	0.70	0.98	0.74	1.31
PC 40:9; [M-Ac-H]-@5.41	ME181056	0.78	1.16	1.06	1.30	0.79	1.06	0.63	1.22
PI 38:3; [M-H]-@6.08	ME181179	0.72	1.25	0.98	1.16	0.82	1.18	0.62	1.27
PI 40:5; [M-H]-@5.95	ME181185	0.86	1.10	0.93	1.37	0.75	1.24	0.61	1.13
PI 40:6; [M-H]-@5.73	ME181186	0.88	1.29	0.91	1.29	0.67	1.30	0.59	1.07
PE 42:1; [M-H]-@8.87	ME181127	0.71	1.23	0.77	1.47	0.76	1.24	0.82	1.00
PC 30:0; [M-Ac-H]-@5.91	ME181005	0.76	1.41	0.86	1.22	0.68	1.24	0.94	0.88
plasmenyl-PE 36:0; [M-H]-@8.14	ME181226	0.73	1.51	0.88	1.32	0.80	1.10	0.77	0.90
PS 40:7; [M-H]-@5.31	ME181202	0.68	1.30	1.24	1.06	0.81	1.13	0.86	0.92
PC 30:1; [M-Ac-H]-@5.42	ME181006	0.70	1.37	0.93	1.04	1.01	1.24	0.83	0.86
PC 31:0; [M-Ac-H]-@6.26	ME181007	0.63	1.32	0.94	1.11	1.14	1.03	0.92	0.90
PC 34:5; [M-Ac-H]-@5.15	ME181022	0.90	1.16	0.45	0.90	1.40	1.38	0.93	0.88
PC 40:8; [M-Ac-H]-@5.78	ME181055	1.13	1.23	0.89	1.20	1.13	0.97	0.40	1.06
PI 40:4; [M-H]-@6.30	ME181184	0.87	1.45	0.79	1.12	1.25	1.12	0.39	1.01
PG 42:8; [M-H]-@5.18	ME181167	0.71	0.81	1.01	1.22	1.30	1.00	0.89	1.05
CL 76:1; [M-2H](2-)@7.49	ME180939	1.05	1.15	0.97	1.33	1.01	0.78	0.76	0.94
CL 76:4; [M-2H](2-)@6.45	ME180946	1.15	1.00	0.88	1.50	1.13	0.79	0.78	0.78
PC 37:1; [M-Ac-H]-@7.65	ME181037	1.01	0.81	0.85	1.54	1.05	0.94	0.77	1.03
PI 38:6; [M-H]-@5.12	ME181182	1.19	0.62	0.87	1.54	0.91	0.91	0.95	1.00
PA 38:5; [M-H]-@6.20	ME181001	1.17	1.22	1.03	0.57	0.77	1.22	0.98	1.04
plasmenyl-PE 33:0; [M-H]-@7.33	ME181219	1.08	1.20	0.92	0.69	0.96	1.37	0.86	0.91
PC 35:4; [M-Ac-H]-@5.93	ME181027	1.04	1.38	0.98	0.77	0.97	1.30	0.79	0.76
plasmenyl-PE 40:5; [M-H]-@7.38	ME181239	1.09	1.32	0.82	0.86	0.97	1.27	0.91	0.76
plasmenyl-PE 40:6; [M-H]-@7.18	ME181240	0.97	1.51	0.73	0.91	0.91	1.55	0.67	0.74
PC 33:2; [M-Ac-H]-@5.97	ME181014	0.88	1.41	1.01	1.13	0.97	1.20	0.80	0.61
PS 37:1; [M-H]-@6.48	ME181193	0.99	1.59	0.78	1.15	0.97	1.24	0.68	0.61
PC 36:2; [M-Ac-H]-@7.74	ME181031	1.11	1.08	0.84	0.88	1.28	0.66	0.94	1.22
PS 42:10; [M-H]-@4.76	ME181205	1.21	1.32	0.79	0.87	1.04	0.72	1.07	0.98
PS 38:6; [M-H]-@5.18	ME181198	1.28	1.04	0.99	0.95	1.04	1.19	0.66	0.85
PG 35:3; [M-H]-@6.27	ME181147	1.23	1.28	0.84	0.86	1.08	1.09	0.66	0.96
PC 40:7; [M-Ac-H]-@6.18	ME181054	1.27	1.23	0.69	1.00	1.11	1.24	0.62	0.85
plasmenyl-PE 35:0; [M-H]-@7.81	ME181225	1.33	1.20	0.69	0.87	1.13	1.21	0.75	0.82
PA 34:0; [M-H]-@7.01	ME180997	1.33	0.95	1.00	1.09	1.07	0.83	0.85	0.87
PC 36:0; [M-Ac-H]-@7.86	ME181029	1.31	1.05	0.87	1.15	1.19	0.82	0.61	1.00
PE 40:5; [M-H]-@6.34	ME181117	1.27	1.03	0.85	1.05	1.15	0.93	0.75	0.98
plasmenyl-PE 34:2; [M-H]-@6.70	ME181223	1.44	0.98	0.94	0.75	1.40	1.01	0.80	0.68
PG 36:4; [M-H]-@5.40	ME181153	1.13	0.93	0.78	0.96	1.33	0.89	1.02	0.95
PC 38:5; [M-Ac-H]-@6.38	ME181046	1.18	1.00	0.87	0.88	1.22	0.98	1.06	0.81
PE 39:4; [M-H]-@7.16	ME181107	1.24	0.93	0.88	0.92	1.19	0.91	1.01	0.92
PC 36:4; [M-Ac-H]-@6.09	ME181034	1.15	1.15	0.89	0.84	1.28	1.07	0.87	0.75
PC 37:4; [M-Ac-H]-@6.58	ME181039	1.46	0.92	0.83	0.78	1.30	1.09	0.68	0.93
PE 34:0; [M-H]-@7.28	ME181064	1.28	0.90	0.85	0.92	1.30	0.98	0.88	0.89
PC 37:5; [M-Ac-H]-@6.05	ME181040	1.32	0.98	0.91	0.84	1.23	1.03	0.74	0.94
PC 38:4; [M-Ac-H]-@6.80	ME181045	1.26	1.03	0.86	0.87	1.28	0.96	0.79	0.94
PE 38:4; [M-H]-@6.12	ME181100	1.31	1.06	0.78	0.83	1.29	1.03	0.84	0.86
PE 40:8; [M-H]-@5.93	ME181123	1.37	0.97	0.84	0.78	1.37	0.94	0.84	0.89
CL 78:5; [M-2H](2-)@6.34	ME180962	1.18	1.03	0.79	0.89	1.16	1.19	0.82	0.93
PC 34:0; [M-Ac-H]-@7.30	ME181016	1.32	1.03	0.83	0.97	1.15	1.08	0.75	0.88
plasmenyl-PE 34:0; [M-H]-@7.61	ME181221	1.30	1.02	0.88	0.91	1.21	1.09	0.81	0.77
PC 35:2; [M-Ac-H]-@6.59	ME181025	0.98	0.85	0.97	1.19	1.21	0.90	0.84	1.05
CL 70:1; [M-2H](2-)@6.12	ME180916	0.79	0.93	0.97	1.18	1.08	0.94	0.94	1.17
CL 74:1; [M-2H](2-)@6.76	ME180933	0.92	0.98	0.97	1.19	1.07	0.88	0.81	1.18
PE 36:2; [M-H]-@6.24	ME181081	1.11	1.02	0.94	0.99	1.16	0.96	0.70	1.11
PE 39:5; [M-H]-@6.76	ME181108	1.04	0.92	0.85	1.07	1.22	0.84	0.83	1.23
CL 78:1; [M-2H](2-)@7.35	ME180952	1.13	0.85	0.94	1.08	1.00	1.11	0.82	1.08
CL 78:3; [M-2H](2-)@6.82	ME180959	1.19	1.03	1.04	0.98	0.98	0.77	0.86	1.16
PE 40:4; [M-H]-@7.19	ME181115	1.18	0.86	1.05	0.97	1.03	0.87	0.90	1.13
PE 40:4; [M-H]-@7.42	ME181114	1.19	0.84	1.06	0.97	1.04	0.88	0.90	1.13
PS 40:8; [M-H]-@4.86	ME181203	1.13	1.00	0.95	1.02	0.88	0.94	1.10	0.97
CL 82:6; [M-2H](2-)@6.91	ME180982	1.12	0.93	0.95	1.15	1.00	0.82	0.99	1.04
PC 36:1; [M-Ac-H]-@7.39	ME181030	1.10	0.98	0.86	1.07	1.09	0.95	0.90	1.04
CL 74:5; [M-2H](2-)@5.75	ME180937	0.90	1.18	1.01	0.97	0.87	1.01	1.06	0.99
PC 36:3; [M-Ac-H]-@6.42	ME181033	1.01	1.16	1.00	0.96	0.93	1.00	1.09	0.85
PE 36:6; [M-H]-@5.56	ME181085	0.92	1.17	1.03	0.90	0.95	1.08	1.05	0.90
PC 34:2; [M-Ac-H]-@6.24	ME181019	0.90	1.06	1.00	1.00	1.01	1.06	1.06	0.91
PC 36:2; [M-Ac-H]-@6.88	ME181032	0.87	1.01	1.08	1.02	0.94	0.98	1.10	1.00
CL 82:12; [M-2H](2-)@5.96	ME180977	1.01	0.98	1.02	0.75	1.07	1.01	1.04	1.12
PE 40:7; [M-H]-@6.04	ME181122	1.10	1.04	0.94	0.87	1.07	1.07	0.98	0.93
PE 40:7; [M-H]-@6.26	ME181121	1.10	1.04	0.94	0.87	1.07	1.07	0.98	0.93
PG 36:2; [M-H]-@5.78	ME181149	1.11	0.98	1.03	0.82	1.07	0.98	1.06	0.94
PG 36:2; [M-H]-@6.05	ME181150	1.11	0.98	1.03	0.82	1.07	0.98	1.06	0.94
plasmenyl-PE 38:6; [M-H]-@6.52	ME181237	1.06	1.06	0.98	0.99	1.06	1.06	0.82	0.99
PC 40:4; [M-Ac-H]-@7.35	ME181051	0.95	1.07	1.00	0.88	1.05	1.07	0.96	1.01
plasmenyl-PE 32:0; [M-H]-@7.08	ME181217	0.99	1.01	0.90	1.00	1.02	1.12	0.98	0.97
PE 40:6; [M-H]-@5.98	ME181119	0.94	1.05	1.08	1.05	1.17	0.99	0.81	0.91
plasmenyl-PE 36:1; [M-H]-@7.68	ME181227	1.11	1.20	1.05	1.12	1.09	0.88	0.83	0.71
CL 82:10; [M-2H](2-)@6.30	ME180975	1.22	1.11	1.00	0.92	0.98	1.06	0.93	0.79
plasmenyl-PE 36:2; [M-H]-@7.29	ME181228	1.17	1.11	0.94	1.02	1.07	1.01	0.89	0.79
CL 80:13; [M-2H](2-)@6.05	ME180970	1.24	1.00	1.01	0.66	1.02	0.93	1.21	0.92
PE 39:7; [M-H]-@6.08	ME181110	1.12	1.01	1.23	0.69	1.03	1.04	1.10	0.78
PE 34:4; [M-H]-@5.70	ME181070	0.96	1.08	0.96	0.70	1.25	1.05	1.18	0.82
PC 34:1; [M-Ac-H]-@6.68	ME181018	0.96	0.92	1.07	0.91	1.11	1.11	1.21	0.72
PE 37:4; [M-H]-@6.68	ME181088	1.03	0.85	1.07	0.87	1.17	0.95	1.11	0.93
PC 35:1; [M-Ac-H]-@7.03	ME181024	0.85	1.09	0.80	1.22	1.08	1.19	0.73	1.03
CerP 42:1; [M-H]-@8.29	ME180993	0.95	1.25	0.81	1.13	0.91	1.11	0.76	1.07
PC 36:5; [M-Ac-H]-@5.67	ME181035	0.81	1.15	0.92	1.15	0.84	1.14	0.95	1.04
PC 33:0; [M-Ac-H]-@6.87	ME181012	0.84	1.19	0.75	1.06	1.03	1.20	0.88	1.05
PE 38:3; [M-H]-@6.44	ME181097	0.83	1.15	0.88	1.06	0.98	1.14	0.88	1.08
PC 38:7; [M-Ac-H]-@5.54	ME181048	1.11	1.13	0.82	0.92	0.92	1.18	0.92	1.00
PC 38:3; [M-Ac-H]-@7.18	ME181044	1.04	1.18	0.74	0.99	1.09	1.22	0.78	0.96
PE 42:7; [M-H]-@6.94	ME181130	0.99	1.08	0.85	0.93	1.23	1.10	0.86	0.96
CL 78:2; [M-2H](2-)@6.92	ME180958	0.93	1.15	0.98	0.89	1.07	1.04	0.71	1.22
PA 26:3; [M-H]-@1.49	ME180995	0.84	1.24	0.91	0.88	0.75	1.38	0.85	1.14
PI 34:1; [M-H]-@5.69	ME181172	1.03	1.27	0.91	0.96	0.87	1.17	0.68	1.10
PS 40:6; [M-H]-@5.80	ME181201	1.00	1.30	0.95	0.90	0.86	1.24	0.66	1.08
PC 35:3; [M-Ac-H]-@6.12	ME181026	0.89	1.29	0.71	1.33	1.16	0.99	0.79	0.85
PA 28:4; [M-H]-@1.82	ME180996	0.89	1.02	0.75	1.08	1.22	1.16	1.02	0.86
PC 39:4; [M-Ac-H]-@7.16	ME181049	1.08	0.99	0.71	1.17	1.27	1.04	0.80	0.94
PE 41:5; [M-H]-@7.30	ME181125	0.85	0.77	0.60	1.20	1.66	1.01	0.54	1.38
PC 34:1; [M-Ac-H]-@7.87	ME181017	0.99	1.20	0.80	0.54	1.22	1.30	0.50	1.45
PE 42:8; [M-H]-@6.52	ME181131	1.15	0.91	0.72	0.67	1.51	1.18	0.59	1.29
CL 68:0; [M-2H](2-)@7.63	ME180913	1.70	0.73	0.95	1.33	1.10	0.71	0.82	0.67
CL 76:5; [M-2H](2-)@6.06	ME180947	1.54	0.71	0.99	1.29	1.56	0.49	0.72	0.71
PE 40:6; [M-H]-@7.90	ME181120	1.40	0.84	1.15	1.23	1.44	0.61	0.43	0.90
CL 78:6; [M-2H](2-)@6.22	ME180963	1.23	1.24	0.79	0.56	1.34	1.25	0.68	0.91
PC 38:6; [M-Ac-H]-@6.03	ME181047	1.54	1.11	0.68	0.86	1.40	1.20	0.45	0.77
PE 38:4; [M-H]-@7.93	ME181099	1.42	1.05	0.74	0.87	1.49	1.14	0.49	0.79
PC 38:0; [M-Ac-H]-@8.40	ME181042	1.27	1.04	0.74	1.43	1.02	0.95	0.57	0.99
PS 41:6; [M-H]-@5.99	ME181204	1.43	0.91	0.84	1.29	1.20	0.89	0.41	1.03
PC 40:5; [M-Ac-H]-@6.97	ME181052	1.12	1.09	0.75	1.11	1.07	1.05	0.64	1.17
PE 40:5; [M-H]-@7.14	ME181116	1.35	0.92	0.70	1.17	1.09	1.06	0.55	1.15
PC 40:6; [M-Ac-H]-@6.68	ME181053	1.54	1.08	0.60	1.00	1.19	1.10	0.40	1.09
PC 37:6; [M-Ac-H]-@5.91	ME181041	1.31	1.03	0.76	1.11	1.34	1.04	0.54	0.86
PE 40:6; [M-H]-@6.84	ME181118	1.27	0.98	0.72	1.13	1.30	1.02	0.47	1.12
PE 41:6; [M-H]-@7.09	ME181126	1.31	1.09	0.54	1.14	1.34	1.06	0.38	1.13
CL 74:3; [M-2H](2-)@6.26	ME180935	1.41	0.82	1.13	0.88	1.34	0.78	0.71	0.93
PE 39:6; [M-H]-@6.53	ME181109	1.55	0.99	0.78	1.02	1.12	0.84	0.60	1.11
CL 82:8; [M-2H](2-)@6.92	ME180984	1.50	0.84	0.77	0.99	1.46	0.84	0.53	1.07
PE 40:9; [M-H]-@5.50	ME181124	1.43	0.87	0.73	1.09	1.30	0.80	0.66	1.13
CL 80:9; [M-2H](2-)@6.53	ME180974	1.37	0.66	0.86	1.07	1.58	0.77	0.65	1.03
PC 31:1; [M-Ac-H]-@6.17	ME181008	1.21	0.91	0.78	1.05	1.51	0.70	0.63	1.22
CL 72:8; [M-2H](2-)@8.87	ME180931	1.60	0.80	0.69	1.52	1.27	0.78	0.28	1.06
CL 74:10; [M-2H](2-)@8.86	ME180934	1.71	0.75	0.61	1.25	1.30	0.69	0.51	1.18
PC 39:6; [M-Ac-H]-@6.44	ME181050	1.43	0.95	0.54	1.27	1.61	1.12	0.30	0.78
CL 80:10; [M-2H](2-)@6.02	ME180967	1.79	0.90	0.40	1.11	1.45	0.97	0.44	0.94
CL 82:11; [M-2H](2-)@5.77	ME180976	1.69	0.81	0.80	0.89	1.53	0.96	0.43	0.89
CL 82:9; [M-2H](2-)@7.13	ME180985	1.69	0.73	0.67	1.00	1.36	1.01	0.55	0.99
CL 76:8; [M-2H](2-)@6.77	ME180949	1.51	0.65	0.64	0.81	1.80	1.29	0.64	0.67
CL 86:20; [M-2H](2-)@6.59	ME180991	1.48	0.74	0.91	0.65	1.86	1.14	0.83	0.39
CL 80:11; [M-2H](2-)@5.97	ME180968	1.58	0.87	0.61	1.09	1.78	0.82	0.70	0.57
CL 84:11; [M-2H](2-)@6.29	ME180987	1.56	0.74	0.68	1.21	2.04	0.55	0.66	0.56
CL 80:13; [M-2H](2-)@5.62	ME180971	1.60	0.73	0.74	0.59	2.06	0.71	0.89	0.67
CL 80:12; [M-2H](2-)@5.80	ME180969	1.51	0.89	0.79	0.67	1.83	0.82	0.77	0.72
PE 39:7; [M-H]-@5.56	ME181111	1.29	0.80	0.98	0.71	1.89	0.83	0.87	0.62
CL 72:2; [M-2H](2-)@7.75	ME180922	1.76	0.75	1.04	0.94	1.54	0.60	0.85	0.52
CL 72:3; [M-2H](2-)@6.13	ME180924	1.54	0.74	0.87	0.95	1.59	0.70	0.80	0.81
lysoPE 18:0; [M-H]-@2.48	ME181210	1.56	0.69	0.81	0.84	1.83	0.64	0.84	0.78
lysoPE 18:0; [M-H]-@2.92	ME181209	1.56	0.69	0.81	0.84	1.83	0.64	0.84	0.78
CL 82:15; [M-2H](2-)@5.73	ME180979	1.88	0.75	0.80	0.66	1.61	0.72	0.83	0.75
CL 82:17; [M-2H](2-)@5.53	ME180980	1.78	0.81	0.79	0.90	1.63	0.61	0.62	0.87
PG 34:2; [M-H]-@5.30	ME181142	1.06	0.55	1.19	1.15	1.25	0.55	1.12	1.12
CL 76:3; [M-2H](2-)@6.84	ME180944	1.28	0.65	0.93	1.10	1.19	0.46	1.12	1.27
CL 76:3; [M-2H](2-)@7.19	ME180945	1.29	0.65	0.94	1.11	1.13	0.44	1.14	1.28
CL 82:13; [M-2H](2-)@5.61	ME180978	1.55	0.78	0.82	0.88	1.05	1.06	1.07	0.79
CL 80:8; [M-2H](2-)@6.82	ME180973	1.71	0.81	0.60	0.78	1.12	0.81	1.05	1.13
CL 82:7; [M-2H](2-)@6.93	ME180983	1.61	0.77	0.86	0.73	1.26	0.80	1.00	0.97
PE 37:6; [M-H]-@5.97	ME181091	1.47	0.79	0.83	0.75	1.27	0.96	1.03	0.91
CL 76:11; [M-2H](2-)@5.93	ME180942	1.55	0.76	0.71	0.86	1.35	0.78	0.95	1.04
CL 86:13; [M-2H](2-)@6.95	ME180990	1.50	0.81	0.71	0.91	1.51	0.81	0.78	0.98
lysoPE 17:0; [M-H]-@2.09	ME181208	1.57	0.62	1.01	0.69	1.60	0.73	1.04	0.74
CL 78:11; [M-2H](2-)@5.96	ME180954	1.47	0.70	1.05	0.87	1.33	0.66	1.08	0.85
CL 80:7; [M-2H](2-)@7.14	ME180972	1.56	0.74	0.91	0.74	1.44	0.71	1.06	0.84
CL 72:3; [M-2H](2-)@6.74	ME180923	1.19	0.61	1.16	0.82	1.31	0.73	1.13	1.04
PG 40:5; [M-H]-@5.61	ME181160	1.35	0.63	1.07	0.76	1.19	1.00	1.16	0.85
PA 42:6; [M-H]-@5.55	ME181003	1.22	0.92	1.12	0.82	1.08	0.92	1.16	0.76
PE 42:8; [M-H]-@5.68	ME181132	1.27	0.89	1.01	0.83	1.25	0.83	1.18	0.74
CL 76:7; [M-2H](2-)@6.70	ME180948	1.43	0.77	1.09	0.75	1.18	0.77	1.18	0.83
CL 78:7; [M-2H](2-)@6.12	ME180964	1.37	0.87	1.04	0.86	1.19	0.81	1.02	0.85
PA 35:1; [M-H]-@6.10	ME180998	0.35	1.94	0.98	0.97	0.84	1.26	0.50	1.16
PA 35:2; [M-H]-@5.67	ME180999	0.34	1.85	0.91	0.86	1.26	1.28	0.44	1.06
PA 37:4; [M-H]-@5.65	ME181000	0.40	1.99	0.80	0.75	1.16	1.43	0.42	1.04
PG 42:10; [M-H]-@4.59	ME181165	0.49	1.36	0.85	0.78	0.53	2.05	0.89	1.05
PI 36:2; [M-H]-@5.82	ME181175	0.58	1.29	1.17	0.88	0.60	1.40	1.12	0.95
PC 32:2; [M-Ac-H]-@5.63	ME181011	0.58	1.59	0.76	1.17	0.48	1.49	1.04	0.88
PG 40:8; [M-H]-@4.59	ME181163	0.50	1.45	0.87	0.94	0.53	1.69	0.97	1.04
PG 42:11; [M-H]-@4.16	ME181166	0.38	0.99	0.77	0.95	1.15	1.48	0.96	1.32
PE 38:5; [M-H]-@5.74	ME181102	0.38	1.53	0.50	1.40	0.58	1.30	1.13	1.18
PA 43:5; [M-H]-@6.49	ME181004	0.84	1.25	0.52	1.53	0.77	1.40	0.38	1.31
PC 42:10; [M-Ac-H]-@5.72	ME181057	0.70	1.18	0.79	1.55	0.74	1.24	0.44	1.36
PG 44:12; [M-H]-@4.46	ME181171	0.61	1.43	0.58	1.27	0.52	1.59	0.53	1.46
PC 36:0; [M-Ac-H]-@7.30	ME181028	0.57	1.35	0.71	1.27	0.76	1.36	0.74	1.25
PG 44:11; [M-H]-@4.81	ME181170	0.74	1.11	0.55	1.43	0.60	1.53	0.76	1.28
lysoPE 18:2; [M-H]-@1.36	ME181212	1.53	0.37	0.65	0.68	2.96	0.42	0.76	0.63
lysoPE 20:3; [M-H]-@1.65	ME181213	1.51	0.34	0.66	0.66	2.91	0.59	0.66	0.67
lysoPE 16:0; [M-H]-@1.66	ME181207	1.17	0.59	0.92	0.71	1.99	0.55	1.32	0.76
lysoPE 20:4; [M-H]-@1.30	ME181214	1.12	0.52	0.88	1.02	2.26	0.50	0.90	0.80
CL 76:12; [M-2H](2-)@8.84	ME180943	2.28	0.38	0.60	1.79	1.48	0.47	0.28	0.71
CL 72:10; [M-2H](2-)@6.19	ME180921	1.90	1.00	1.01	0.67	1.11	1.15	0.62	0.54
CL 78:12; [M-2H](2-)@6.79	ME180955	2.30	1.08	0.75	0.33	1.07	1.35	0.44	0.68
PA 42:4; [M-H]-@7.33	ME181002	2.06	0.68	0.98	0.63	1.29	0.58	1.24	0.54
CL 84:13; [M-2H](2-)@5.96	ME180988	2.15	0.75	0.61	0.62	2.40	0.66	0.44	0.37
PC 33:3; [M-Ac-H]-@7.28	ME181015	2.24	0.97	0.46	0.62	1.61	0.85	0.67	0.59
CL 76:10; [M-2H](2-)@6.78	ME180940	2.48	0.66	0.69	0.47	1.79	0.72	0.55	0.64
PG 38:5; [M-H]-@5.51	ME181158	2.23	0.50	0.77	0.60	1.83	0.75	0.83	0.49

Factors:

F1	Side:L \| TIME_DAYS:-
F2	Side:L \| TIME_DAYS:10
F3	Side:L \| TIME_DAYS:30
F4	Side:L \| TIME_DAYS:60
F5	Side:R \| TIME_DAYS:-
F6	Side:R \| TIME_DAYS:10
F7	Side:R \| TIME_DAYS:30
F8	Side:R \| TIME_DAYS:60

Data matrix